Accenture’s IBD SmartSelect Composite Rating increased from 94 to 96 on Tuesday. Is Accenture a stock you’re keeping an eye on? Accenture stock now outperforms 96% of all stocks on the most important stock-picking criterion, according to the latest rating./n
Read More
